Skip to main content
Log in

Polycythemia as the first manifestation of Cushing’s disease

  • Case Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

A 39-yr-old man presented to our hospital with unexplained erythrocytosis and hypertension. His follow-up for erythrocytosis had begun 2 yr earlier in another hospital and he had been diagnosed with polycythemia rubra vera. On admission to our hospital he was hypertensive (165/95 mmHg) and, except for the presence of moon-like face and facial plethora, his physical examination was normal. His hemoglobin concentration was 19.2 g/dl, and hematocrit was 58.9% with an increased red blood cell mass of 58 ml/kg as measured by radioisotope (Cr51). Blood film, other hematological indices except for elevated leukocyte alkaline phosphatase score, arterial gas analysis, and examination of aspirated bone marrow were all normal. An abdominal ultrasonography showed no evidence of splenomegaly. A diagnosis of probable secondary erythrocytosis was made. Early-morning serum cortisol and 24-h urinary free cortisol concentration as well as serum ACTH were high. Serum cortisol was not suppressed by low-dose dexamethasone, but suppressed by high-dose dexamethasone. Pituitary magnetic resonance imaging showed no lesion. After inferior petrosal sinus sampling suggesting right-central ACTH secretion, the patient underwent transnasal-transsphenoidal pituitary adenomectomy. Both hypercortisolemia and erythrocytosis regressed completely after the adenomectomy. After the operation, the patient’s hemoglobin concentration and hematocrit decreased steadily, and 1 month post-adenomectomy his hemoglobin is 14.9 g/dl and hematocrit 44.8%. Thus, Cushing’s syndrome should be a routine part of evaluation of unexplained polycythemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Prchal JT. Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders. Semin Hematol 2001, 38 (Suppl 2): 10–20.

    Article  CAS  PubMed  Google Scholar 

  2. Prchal JT. Classification and molecular biology of polycythemias (erythrocytoses) and thrombocytosis. Hematol Oncol Clin North Am 2003, 17:1151–8.

    Article  PubMed  Google Scholar 

  3. McMullin MF, Bareford D, Campbell P, et al. Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis. Br J Haematol 2005, 130: 174–95.

    Article  PubMed  Google Scholar 

  4. Miller WL, Tyrrell JB. Endocrinology and metabolism. New York: McGraw-Hill, 1995, 555–711.

    Google Scholar 

  5. Bauer A, Tronche F, Wessely O, et al. The glucocorticoid receptor is required for stress erythropoiesis. Genes Dev 1999, 13: 2996–3002.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. von Lindern M, Zauner W, Mellitzer G, et al. The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kitto enhance and sustain proliferation of erythroid progenitors in vitro. Blood 1999, 94: 550–9.

    Google Scholar 

  7. Gordon AS, Zanjani ED, Levere RD, Kappas A. Stimulation of mammalian erythropoiesis by 5beta-H steroid metabolites. Proc Natl Acad Sci U S A 1970, 65: 919–24.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Kutti J, Ridell B. Epidemiology of the myeloproliferative disorders: essential thrombocythaemia, polycythaemia vera and idiopathic myelofibrosis. Pathol Biol (Paris) 2001, 49: 164–6.

    Article  CAS  Google Scholar 

  9. Wasserman LR. The management of polycythaemia vera. Br J Haematol 1971, 21: 371–6.

    Article  CAS  PubMed  Google Scholar 

  10. Lindemann R, Trygstad O, Halvorsen S. Pituitary control of erythropoiesis. Scand J Haematol 1969, 6: 77–86.

    Article  CAS  PubMed  Google Scholar 

  11. Leberbauer C, Boulme F, Unfried G, Huber J, Beug H, Mullner EW. Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors. Blood 2005, 105: 85–94.

    Article  CAS  PubMed  Google Scholar 

  12. Golde DW, Bersch N, Cline MJ. Potentiation of erythropoiesis in vitro by dexamethasone. J Clin Invest 1976, 57: 57–62.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Udupa KB, Crabtree HM, Lipschitz DA. In vitro culture of proerythroblasts: characterization of proliferative response to erythropoietin and steroids. Br J Haematol 1986, 62: 705–14.

    Article  CAS  PubMed  Google Scholar 

  14. Roodman GD, Lee J, Gidari AS. Effects of dexamethasone on erythroid colony and burst formation from human fetal liver and adult marrow. Br J Haematol 1983, 53: 621–8.

    Article  CAS  PubMed  Google Scholar 

  15. Kelly JJ, Martin A, Whitworth JA. Role of erythropoietin in cortisol-induced hypertension. J Hum Hypertens 2000, 14: 195–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Gursoy MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gursoy, A., Dogruk Unal, A., Ayturk, S. et al. Polycythemia as the first manifestation of Cushing’s disease. J Endocrinol Invest 29, 742–744 (2006). https://doi.org/10.1007/BF03344186

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03344186

En]Keywords

Navigation